disclosures

In accordance with ACCME standards, MECOP requires that all faculty, planners, speakers and reviewers complete a Disclosure Statement so that relevant relationships with ineligible companies are identified and any potential conflicts of interest are resolved prior to the CME program.

The planners, reviewers and symposium co-chairs have no relevant financial relationships with ineligible companies.

The following speakers and panelists have no relevant relationships with ineligible companies:

David Arnold, MD
Elizabeth B. Bell, MD
Ryan Carey, MD
Francisco Civantos, MD
Meghan Crawley, MD
Jessica Crystal, MD
Joseph Curry, MD
Deepa Danan, MD
Liliana Ein, MD
Katherine Fedder, MD
Lynn Feun, MD
Jenn Gross, MD

Erin Kaye, MD
Jason Leibowitz, MD
Elizabeth Nicolli, MD
Andrew Rong, MD
Sandeep Samant, MD
Stuart Samuels, MD
Zoukaa Sargi, MD
Madeline Strohl, MD
Melanie Townsend, MD
Samuel Trosman, MD
David Tse, MD
Don Weed, MD

The following speakers and panelists have relevant relationships with ineligible companies as follows:

Matthew C. Abramowitz, MD, discloses that he is a speaker for Varian.
Elizabeth Franzmann, MD, discloses that she is an investigator for Replimune and that she is on an advisory board for Ferndale.
Neil D. Gross, M.D. discloses that he is on the advisory boards of Geovax, Regeneron, and Merck. Additionally he receives honoraria and royalties from Up-to-Date, AiCME, OncLive, and MJH Life Science, as well as research support from Regeneron.
Leonel Hernandez, MD, discloses that he serves on an advisory board for Bristol Myers Squibb.
Jennifer Tang, MD, discloses that she is an investigator for Replimune and that she is on an advisory board for Ferndale.
Erik A. Williams, M.D., discloses that he is a consultant for Foundation Medical, Inc, subsidiary of Roche.

All of the above relevant financial relationships with ineligible companies were mitigated through advanced content review.

disclosures

This website uses cookies.